Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial
Article in BMC Cancer (September 2022)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in BMC Cancer (September 2022)
Article in Drug Delivery (July 2022)
Article in Frontiers in Oncology (November 2021)